Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients Results from the OVCAD study

E. I. Braicu*, C. Fotopoulou, T. Van Gorp, R. Richter, R. Chekerov, C. Hall, H. Butz, D. Cacsire Castillo-Tong, S. Mahner, R. Zeillinger, N. Concin, I. Vergote, J. Sehouli

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)245-251
JournalGynecologic Oncology
Volume128
Issue number2
DOIs
Publication statusPublished - Feb 2013

Keywords

  • Ovarian cancer
  • HE4
  • CA125
  • Surgical outcome

Cite this